EUVIMEDEUVIMED entdecken
Editorial

Could GLP-1RAs improve outcomes for patients with chronic migraine?

Tsung-Wei Hou, Vitoria Acar, Hsiangkuo Yuan

Expert Review of Clinical Pharmacology · 03.08.2026 · 19 (8) · 697-700

DOI: 10.1080/17512433.2026.2710153 ↗

Kurz gefasst

Editorial in der Zeitschrift Expert Review of Clinical Pharmacology, online erschienen am 28.07.2026. Verfasst von Tsung-Wei Hou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Glucagon-like peptide-1 receptor agonistchronic migraineheadacheidiopathic intracranial hypertensionmigraineobesity

Autor:innen und Institutionen

  • Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Department of Neurology, Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan.

Zitieren

APA

Hou, T. W., Acar, V., & Yuan, H. (2026). Could GLP-1RAs improve outcomes for patients with chronic migraine?. Expert Review of Clinical Pharmacology, 19(8), 697-700. https://doi.org/10.1080/17512433.2026.2710153

Vancouver

Hou TW, Acar V, Yuan H. Could GLP-1RAs improve outcomes for patients with chronic migraine?. Expert Review of Clinical Pharmacology. 2026;19(8):697-700. doi:10.1080/17512433.2026.2710153

BibTeX
@article{Hou2026,
  author = {Hou, Tsung-Wei and Acar, Vitoria and Yuan, Hsiangkuo},
  title = {Could GLP-1RAs improve outcomes for patients with chronic migraine?},
  journal = {Expert Review of Clinical Pharmacology},
  year = {2026},
  volume = {19},
  number = {8},
  pages = {697--700},
  doi = {10.1080/17512433.2026.2710153}
}
Kostenlos starten →